Metastatic organ count stratifies survival in immunotherapy-treated metastatic colorectal cancer: a retrospective cohort study
Increased metastatic organ count in patients with mCRC was associated with decreased immunotherapy ORR and worse prognosis, with a particularly pronounced effect observed in patients with lung metastasis.
Authors
- Kunhao Bai (ORCID: https://orcid.org/0000-0003-1184-7576)
- Jinshan Huang (ORCID: https://orcid.org/0000-0003-2040-7046)
- Yan Wang (ORCID: https://orcid.org/0000-0003-4862-3912)
- Zhi‐Qiang Wang (ORCID: https://orcid.org/0000-0003-2658-8781)
- Na Wang
- Yiyang Zhang (ORCID: https://orcid.org/0000-0002-2309-2089)
- Jiahao Tian (ORCID: https://orcid.org/0000-0002-0255-3499)
- Hai-Yan Fu
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1679041
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00